» Articles » PMID: 2347583

Use of Denaturing Gradient Gel Electrophoresis for Detection of Mutation and Prospective Diagnosis in Late Onset Ornithine Transcarbamylase Deficiency

Overview
Journal Genomics
Specialty Genetics
Date 1990 Jun 1
PMID 2347583
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Ornithine transcarbamylase (ornithine carbamoyltransferase, EC 2.1.3.3) deficiency is an X-linked inborn error of metabolism with considerable phenotypic variability in affected males. Using a combination of the polymerase chain reaction and denaturing gradient gel electrophoresis (DGGE), we defined a mutation in a family in whom affected males have significant residual enzyme activity. A C----T change in the first nucleotide of codon 277 resulted in the substitution of a tryptophan for an arginine at amino acid 245 of the mature protein. This change appears to represent a deleterious mutation rather than a polymorphism on the basis of several factors: the change occurs at a highly conserved arginine residue, significant size and change differences exist between arginine and tryptophan, and this change was not seen on DGGE screening of 26 unrelated individuals representing 43 chromosomes. Diagnosis of an at-risk male newborn in this family was performed using direct mutational analysis. In families with partial enzyme deficiencies in whom biochemical data may be difficult to evaluate, direct detection of mutations at the OTC locus permits definitive diagnosis. This represents the first description of a mutation in late onset OTC deficiency and demonstrates direct mutational analysis by DGGE for prospective diagnosis in a genetic disorder.

Citing Articles

Urea cycle disorders in India: clinical course, biochemical and genetic investigations, and prenatal testing.

Bijarnia-Mahay S, Haberle J, Jalan A, Puri R, Kohli S, Kudalkar K Orphanet J Rare Dis. 2018; 13(1):174.

PMID: 30285816 PMC: 6167905. DOI: 10.1186/s13023-018-0908-1.


Antepartum ornithine transcarbamylase deficiency.

Nakajima H, Sasaki Y, Maeda T, Takeda M, Hara N, Nakanishi K Case Rep Gastroenterol. 2015; 8(3):337-45.

PMID: 25759629 PMC: 4337171. DOI: 10.1159/000369131.


Paternal transmission and slow elimination of mutant alleles associated with late-onset ornithine transcarbamylase deficiency in male patients.

Numata S, Harada E, Maeno Y, Ueki I, Watanabe Y, Fujii C J Hum Genet. 2007; 53(1):10-17.

PMID: 18030415 DOI: 10.1007/s10038-007-0212-8.


Identification of new mutations in the ornithine transcarbamylase (OTC) gene in Korean families.

Yoo H, Kim G, Lee D J Inherit Metab Dis. 1996; 19(1):31-42.

PMID: 8830175 DOI: 10.1007/BF01799346.


Patient selection may affect gene therapy success. Dominant negative effects observed for ornithine transcarbamylase in mouse and human hepatocytes.

Morsy M, Zhao J, Ngo T, Warman A, OBrien W, Graham F J Clin Invest. 1996; 97(3):826-32.

PMID: 8609240 PMC: 507121. DOI: 10.1172/JCI118482.